Janux Therapeutics, Inc. · NASDAQ:JANX
Point72 Asset Management, L.P. reported a 5.00% stake in Janux Therapeutics, Inc. (Schedule 13G)
Event Apr 28, 2026 · Filed Apr 29, 2026
Point72 Asset Management, L.P. reported a 5.00% stake in Janux Therapeutics, Inc., 3,069,759 shares, as a passive investor on Apr 28, 2026. Filed Apr 29, 2026 (Schedule 13G).
- Stake
- 5.00%
- Shares
- 3,069,759
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.00% | 3,069,759 |
| Point72 Capital Advisors, Inc. | 5.00% | 3,069,759 |
| Steven A. Cohen | 5.00% | 3,069,759 |
Source
Related
- Janux Therapeutics, Inc.
- Point72 Asset Management, L.P.
- Janux Therapeutics, Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Apr 29, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Aug 13, 2026
- Form 4 · Campbell David Alan · Jul 31, 2026
- Schedule 13G/A · BlackRock, Inc. · Jul 28, 2026
- Form 4 · Campbell David Alan · Jul 10, 2026
- Form 4 · RA Capital Nexus Fund II, L.P. · Jun 12, 2026